Ximelagatran - A Promising New Drug in Thromboembolic Disorders

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|11|4|527-538

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.11, Iss.4, 2005-02, pp. : 527-538

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New drug targets for resistant hypertension look promising

By  

Inpharma, Vol. 1, Iss. 1286, 2001-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Adrenomedullin: a new and promising target for drug discovery

By García Mario A   Martín-Santamaría Sonsoles   de Pascual-Teresa Beatriz   Ramos Ana   Julián Miguel   Martínez Alfredo  

Expert Opinion on Therapeutic Targets, Vol. 10, Iss. 2, 2006-04 ,pp. : 303-317

Informa Healthcare

Access to resources Recommend Favorite

Why is the Plasmodium falciparum hexose transporter a promising new drug target?

By Joët T   Morin C   Fischbarg J   Louw Abraham I   Eckstein-Ludwig U   Woodrow C   Krishna S  

Expert Opinion on Therapeutic Targets, Vol. 7, Iss. 5, 2003-10 ,pp. : 593-602

Informa Healthcare

Access to resources Recommend Favorite

Clevidipine butyrate: a promising new drug for the management of acute hypertension

By Bergese Sergio D   Puente Erika G  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 2, 2010-02 ,pp. : 281-295

Informa Healthcare

Access to resources Recommend Favorite

LB80380: a promising new drug for the treatment of chronic hepatitis B

By Fung James   Lai Ching-Lung   Yuen Man-Fung  

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 10, 2008-10 ,pp. : 1581-1588

Informa Healthcare

Access to resources Recommend Favorite